Progress in research on recombinant vector vaccine against SARS-CoV-2
Chinese Journal of Biologicals
; 34(6):730-739, 2021.
Article
in Chinese
| EMBASE | ID: covidwho-1894087
ABSTRACT
The global epidemic of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) poses a great threat to human life and health. At present, various types of vaccines have been approved for use worldwide to prevent the spread of the epidemic, among which recombinant vector vaccine plays an important role. Up to May 25, 2021, four vector vaccines have been approved for use in different countries, while 17 ones are in clinical trials and more than 40 ones in preclinical studies. This paper summarizes the research status of recombinant vector vaccine against SARS-CoV-2 in the world.
Search on Google
Collection:
Databases of international organizations
Database:
EMBASE
Topics:
Vaccines
Language:
Chinese
Journal:
Chinese Journal of Biologicals
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS